About Genes 2Me Private Limited
Data last updated: 06 February 2026
Genes 2Me Private Limited is a private limited company based in Delhi, Delhi, India, recognised as a startup by DPIIT. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 23 August 2019, the company has been in operation for over 7 years.
Registered with ROC Delhi under CIN U73200DL2019PTC354174.
Capital: an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1 Cr. It is led by directors Neeraj Gupta and Ritu Gupta.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Flat No. 234 Somdutt Chamber – Ii 9 Bhikaji Cama Place, Delhi, Delhi, India – 110022.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.72 Cr, a decline of 20% compared to the previous year.
The company is associated with 1 brand - Genes2me. As per MCA filings, the company has open charges of ₹33.85 Cr on record.
For more details, the company can be reached via its website genes2me.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressFlat No. 234 Somdutt Chamber – Ii 9 Bhikaji Cama Place, Delhi, Delhi, India – 110022
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Genes 2Me Private Limited
Genes 2Me Private Limited operates one associated brand: Genes2me. These brands represent Genes 2Me Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Personalized healthcare is delivered via genetics and molecular diagnostics. | genes2me.com |
Competitors & Alternatives of Genes 2Me Private Limited
Brands and companies operating in the same space as Genes 2Me Private Limited include Natera, ImaginAb, Lantern Pharma and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Natera
|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | Redwood City, United States, United States | 2004 |
ImaginAb
|
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | Los Angeles, United States, United States | 2007 |
Lantern Pharma
|
Drug and companion diagnostics for multi-drug resistant cancers are developed. | Dallas, United States, United States | 2013 |
ArcherDX
|
Molecular cancer diagnostic products are developed using patented AMP technology. | Boulder, United States, United States | 2013 |
LifeCell
|
LifeCell is engaged in cord blood banking services. | Chennai, India, India | 2004 |
Rgenta
|
RNA-based therapeutics are developed for multiple disorders. | Cambridge, United States, United States | 2018 |
Variantyx
|
Genomics data analysis platform for healthcare diagnostics is offered. | Boston, United States, United States | 2014 |
Guangzhou Kang Liming Biotechnology
|
Cancer detection kits and screening services are provided. | Guangzhou, China, China | 2015 |
RareCyte
|
Developer of technologies for the analysis of rare and single cells in the blood | Seattle, United States, United States | 2009 |
Strata Oncology
|
Genetic sequencing is provided for late-stage cancer patients. | Ann Arbor, United States, United States | 2015 |
Business Activity of Genes 2Me Private Limited
Genes 2Me Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details for Genes 2Me Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Genes 2Me Private Limited
Genes 2Me Private Limited is audited by K S BAWA & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K S BAWA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Genes 2Me Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Genes 2Me Private Limited
Genes 2Me Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Gupta | Director | 23 Aug 2019 | 6 Years 11 Months | Current |
|
Ritu Gupta
Also directs:
Imperial Life Sciences Private Limited, Ils Foundation
|
Director | 23 Aug 2019 | 6 Years 11 Months | Current |
Financials of Genes 2Me Private Limited FY 2025 filings available
Genes 2Me Private Limited reported revenue of ₹21.72 Cr (down 20.00% YoY) for FY 2025.
Ten-year financial statements for Genes 2Me Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Genes 2Me Private Limited
Shareholding and ownership data for Genes 2Me Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Genes 2Me Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2025 | The Hongkong and Shanghai Banking Corporation Limited | ₹3 Cr | Open |
| 12 Sep 2022 | State Bank of India | ₹29.75 Cr | Open |
| 18 Aug 2022 | Hdfc Bank Limited | ₹1.1 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Genes 2Me Private Limited
View historical data on people associated with Genes 2Me Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Genes 2Me Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Genes 2Me Private Limited
GST registrations and filing compliance for Genes 2Me Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Genes 2Me Private Limited
Credit ratings, litigation, and regulatory alerts for Genes 2Me Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genes 2Me Private Limited
MSME payment history for Genes 2Me Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genes 2Me Private Limited
Corporate group structure for Genes 2Me Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genes 2Me Private Limited
MCA filings and documents for Genes 2Me Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Genes 2Me Private Limited
Frequently Asked Questions about Genes 2Me Private Limited
Genes 2Me Private Limited is an active private limited company in the healthcare sector based in Delhi, Delhi, India. It was incorporated on 23 August 2019 (7+ years old) and is registered under CIN U73200DL2019PTC354174.
Genes 2Me Private Limited reported revenue of ₹21.72 Cr for FY 2025 (down 20.00% YoY).
The current directors of Genes 2Me Private Limited are:
- Neeraj Gupta - Director
- Ritu Gupta - Director
The primary industry of Genes 2Me Private Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Yes, Genes 2Me Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Genes 2Me Private Limited can be reached at the registered office: Flat No. 234 Somdutt Chamber – Ii 9 Bhikaji Cama Place, Delhi, Delhi, India – 110022, or through the website genes2me.com.